first glp 1 approval Lilly is now pharma's top revenue company. It just got FDA for an oral GLP-1, but Wall Street isn't celebrating First Oral GLP-1 WEIGHT LOSS

Ethics declarations Competing interests The author declares associations with the following companies: Astra-Zeneca, Bristol-Myers Squibb, Merck Sharpe & Dohme, NovoNordisk and Sanofi-Aventis (advisory board membership

Read the rest of the article to find out

Furthermore, leptin receptor-deficient mice, a mouse model of obesity and diabetes, and people with endogenous glucagon deficiency (pancreatectomised individuals) treated with glucagon antisense oligonucleotide have increased hepatic fat [52, 53]

The vital role of Vitamin B6 (P-5-P) is also currently under intense clinical investigation

7 , e1002341 (2011)